Reliant was formed in August 1999 to capitalize on existing and future pharmaceutical opportunities, initially by acquiring and marketing under-promoted drugs and eventually by developing new formulations and late-stage clinical development candidates. In December 2007, Reliant Pharmaceuticals was acquired by GlaxoSmithKline for $1.65 billion.
Reliant Pharmaceuticals
